HIV INFECTION PREVENTION: EPIDEMIOLOGICAL CHARACTERISTICS, ROUTES OF TRANSMISSION, CLINICAL STAGES, AND PRINCIPLES OF TREATMENT
Keywords:
HIV infection, AIDS, epidemiology, transmission pathways, clinical stages, CD4 lymphocytes, viral load, antiretroviral therapy, PrEP, PEP, vertical transmission, infection prevention and control..Abstract
This scientific narrative review examines the global epidemiology and etiopathogenesis of human immunodeficiency virus (HIV) infection, its sexual, parenteral, and vertical transmission pathways, clinical manifestations, and the four clinical stages defined by the World Health Organization (WHO). Current recommendations concerning laboratory diagnosis, assessment of antiretroviral therapy (ART) effectiveness, pre-exposure and post-exposure prophylaxis, prevention of mother-to-child transmission, and infection prevention and control in healthcare settings are synthesized. According to WHO estimates for the end of 2025, approximately 41.0 million people worldwide were living with HIV, underscoring the need for continuous, integrated prevention and treatment services. The review identifies early diagnosis, uninterrupted ART, risk-adapted prevention, and stigma-free healthcare communication as mutually reinforcing priorities..
References
World Health Organization. HIV and AIDS. Fact sheet. 27 July 2026. https://www.who.int/news-room/fact-sheets/detail/hiv-aids
2. World Health Organization. HIV data and statistics: global estimates for 2025. 2026. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics
3. World Health Organization. WHO clinical staging of HIV disease in adults and adolescents. Annex 1 (clinical staging). https://www.afro.who.int/sites/default/files/2017-06/artadultguidelines.pdf
4. World Health Organization. Consolidated guidelines on differentiated HIV testing services. Geneva: WHO; 2024. ISBN 978-92-4-009639-4. https://www.who.int/india/publications/i/item/9789240096394
5. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: WHO; 2021 (with linked updates). https://www.who.int/publications/i/item/9789240031593
6. World Health Organization. Pre-exposure prophylaxis of HIV infection: WHO guidance and updates, 2025. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/pre-exposure-prophylaxis
7. World Health Organization. Guidelines for HIV post-exposure prophylaxis. Geneva: WHO; 2024. ISBN 978-92-4-009513-7. https://www.who.int/publications/i/item/9789240095137
8. World Health Organization. HIV and AIDS: questions and answers (vertical transmission prevention). https://www.who.int/news-room/questions-and-answers/item/hiv-aids
9. INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795–807. doi:10.1056/NEJMoa1506816.
10. Cohen MS, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375:830–839. doi:10.1056/NEJMoa1600693.
11. Centers for Disease Control and Prevention. Undetectable = Untransmittable. Updated 19 August 2024. https://www.cdc.gov/global-hiv-tb/php/our-approach/undetectable-untransmittable.html
12. UNAIDS. Zero Discrimination Day 2026: People first. 2026. https://www.unaids.org/en/2026-zero-discrimination-day
